We are live on ! Find out more
IART icon

Integra LifeSciences

194 hedge funds and large institutions have $2.2B invested in Integra LifeSciences in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 88 increasing their positions, 62 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

42% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 62

4% more funds holding

Funds holding: 186194 (+8)

4% more capital invested

Capital invested by funds: $2.12B → $2.2B (+$77M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
194
Holders Change
+8
Holders Change %
+4.3%
% of All Funds
5.17%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
21
Increased
88
Reduced
62
Closed
12
Calls
$209K
Puts
Net Calls
+$209K
Net Calls Change
+$146K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$318M -$51.5M -1,653,974 -15%
Vanguard Group
2
Vanguard Group
Pennsylvania
$153M +$3.81M +122,328 +3%
BFA
3
BlackRock Fund Advisors
California
$125M -$427K -13,706 -0.4%
Wells Fargo
4
Wells Fargo
California
$108M +$9.33M +299,572 +10%
CIP
5
Champlain Investment Partners
Vermont
$101M +$1.09M +35,050 +1%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$67.1M +$4.19M +134,402 +7%
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$50.5M -$77.7K -2,494 -0.2%
BIT
8
BlackRock Institutional Trust
California
$48.9M +$347K +11,136 +0.8%
Goldman Sachs
9
Goldman Sachs
New York
$47M +$3.64M +117,020 +9%
SAM
10
Silvercrest Asset Management
New York
$46.1M +$1.22M +39,228 +3%
WHG
11
Westwood Holdings Group
Texas
$43.8M +$5.42M +174,094 +15%
ClearBridge Investments
12
ClearBridge Investments
New York
$42.9M -$557K -17,880 -1%
VNIM
13
Vaughan Nelson Investment Management
Texas
$40.7M -$9.69M -311,250 -21%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$40.5M +$16.5M +530,426 +79%
Deutsche Bank
15
Deutsche Bank
Germany
$39M +$18.1M +579,834 +100%
State Street
16
State Street
Massachusetts
$38.7M +$996K +31,960 +3%
Westfield Capital Management
17
Westfield Capital Management
Massachusetts
$38.4M +$8.59M +275,820 +32%
Norges Bank
18
Norges Bank
Norway
$37.3M
Fisher Asset Management
19
Fisher Asset Management
Washington
$36.4M -$455K -14,600 -1%
Boston Partners
20
Boston Partners
Massachusetts
$31.2M +$289K +9,286 +1%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$29.3M +$1.89M +60,600 +7%
Lord, Abbett & Co
22
Lord, Abbett & Co
New Jersey
$27.5M +$25.4M +816,006 New
EIP
23
Epoch Investment Partners
New York
$27.1M +$797K +25,578 +3%
O
24
OppenheimerFunds
New York
$25.1M -$749K -24,042 -3%
EVM
25
Eaton Vance Management
Massachusetts
$23.8M +$4.77M +153,280 +28%

IART Hedge Fund Activity: Q1 2016 in Review

194 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2016, worth a combined $2.2B — up 3.6% from $2.12B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IART positions and 12 closed out — a net gain of 9 holders — while 88 added to existing stakes and 62 trimmed.

The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $25.4M. The largest seller was Fidelity Investments, cutting an estimated $51.5M.

  • 194 institutional investors held Integra LifeSciences (IART) as of Q1 2016, up from 186 in Q4 2015.
  • Funds reported $2.2B of Integra LifeSciences stock for Q1 2016, up 3.6% quarter-over-quarter.
  • 21 funds opened new Integra LifeSciences positions in Q1 2016 and 12 closed out, a net change of +9 holders.
  • The largest Integra LifeSciences buyer in Q1 2016 was Lord, Abbett & Co, an estimated $25.4M added.
  • The largest Integra LifeSciences seller in Q1 2016 was Fidelity Investments, an estimated $51.5M sold.

Based on aggregated 13F filings for Q1 2016.